Gewählte Publikation:
SHR
Neuro
Krebs
Kardio
Lipid
Stoffw
Microb
Kneidinger, N; Milger, K; Janitza, S; Ceelen, F; Leuschner, G; Dinkel, J; Königshoff, M; Weig, T; Schramm, R; Winter, H; Behr, J; Neurohr, C.
Lung volumes predict survival in patients with chronic lung allograft dysfunction.
Eur Respir J. 2017; 49(4):
Doi: 10.1183/13993003.01315-2016
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
-
Kneidinger Nikolaus
-
Milger-Kneidinger Katrin
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Identification of disease phenotypes might improve the understanding of patients with chronic lung allograft dysfunction (CLAD). The aim of the study was to assess the impact of pulmonary restriction and air trapping by lung volume measurements at the onset of CLAD.A total of 396 bilateral lung transplant recipients were analysed. At onset, CLAD was further categorised based on plethysmography. A restrictive CLAD (R-CLAD) was defined as a loss of total lung capacity from baseline. CLAD with air trapping (AT-CLAD) was defined as an increased ratio of residual volume to total lung capacity. Outcome was survival after CLAD onset. Patients with insufficient clinical information were excluded (n=95).Of 301 lung transplant recipients, 94 (31.2%) developed CLAD. Patients with R-CLAD (n=20) and AT-CLAD (n=21), respectively, had a significantly worse survival (p<0.001) than patients with non-R/AT-CLAD. Both R-CLAD and AT-CLAD were associated with increased mortality when controlling for multiple confounding variables (hazard ratio (HR) 3.57, 95% CI 1.39-9.18; p=0.008; and HR 2.65, 95% CI 1.05-6.68; p=0.039). Furthermore, measurement of lung volumes was useful to identify patients with combined phenotypes.Measurement of lung volumes in the long-term follow-up of lung transplant recipients allows the identification of patients who are at risk for worse outcome and warrant special consideration.
- Find related publications in this database (using NLM MeSH Indexing)
-
Adult - administration & dosage
-
Azithromycin - therapeutic use
-
Bronchiolitis Obliterans - drug therapy, physiopathology
-
Chronic Disease - administration & dosage
-
Female - administration & dosage
-
Germany - administration & dosage
-
Humans - administration & dosage
-
Lung - physiopathology, surgery
-
Lung Transplantation - adverse effects, mortality
-
Male - administration & dosage
-
Middle Aged - administration & dosage
-
Primary Graft Dysfunction - etiology, mortality, physiopathology
-
Retrospective Studies - administration & dosage
-
Risk Factors - administration & dosage
-
Survival Analysis - administration & dosage
-
Tidal Volume - administration & dosage
-
Transplantation, Homologous - administration & dosage